0000001800 2026-04-24 2026-04-24 0000001800 1 2026-04-24 2026-04-24 0000001800 2 2026-04-24 2026-04-24 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0000001800 ABBOTT LABORATORIES N/A false false S-8 ABBOTT LABORATORIES Equity Common Shares, Without Par Value true 140000000 91.61 12825400000.00 0.0001381 1771187.74 Equity Common Shares, Without Par Value true 15000000 91.61 1374150000.00 0.0001381 189770.12 14199550000.00 1960957.86 0.00 1960957.86 The maximum number of common shares issuable under the Abbott Laboratories 2026 Incentive Stock Program (the "Plan") is subject to adjustment in accordance with certain antidilution provisions of each such program. Accordingly, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement includes an indeterminate number of additional common shares that may be issuable if the antidilution provisions of the Plan become operative. Consists of common shares that are reserved for issuance in respect of awards to be granted under the Plan. Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the Registrant's common shares as reported on the New York Stock Exchange on April 23, 2026, which date is within five business days prior to filing this Registration Statement. The maximum number of common shares issuable under the Abbott Laboratories 2026 Employee Stock Purchase Plan For Non-U.S. Employees (the "ESPP") is subject to adjustment in accordance with certain antidilution provisions of each such program. Accordingly, pursuant to Rule 416 under the Securities Act, this registration statement includes an indeterminate number of additional common shares that may be issuable if the antidilution provisions of the ESPP become operative. Consists of common shares that are reserved for issuance under the ESPP. Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the Registrant's common shares as reported on the New York Stock Exchange on April 23, 2026, which date is within five business days prior to filing this Registration Statement.